However, encouraged by the potential of stem cells to alter disease progression and based on our experience with chimerism induction in transplantation [28], we developed a novel therapeutic approach for DMD by creating Dystrophin-Expressing Chimeric Cells of myoblast origin through the PEG-mediated cell fusion [29]. Here, DMD is linked to Duchenne muscular dystrophy.